The U.S. Food and Drug Administration (FDA) is updating our safety communication to remind the public, health care providers, lab personnel, and lab test developers that biotin, often found in dietary supplements, can significantly interfere with certain lab tests and cause incorrect results that may go undetected. The FDA wants to make the public and health care providers aware about biotin interference with lab tests so that patients, physicians, and laboratories can work together to help prevent adverse events.
The FDA has posted a webpage on Biotin Interference with Troponin Lab Tests – Assays Subject to Biotin Interference to notify the public about troponin assays where the risk of biotin interference has not yet been addressed.
|
|
|
|
No hay comentarios:
Publicar un comentario